Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04006509
Other study ID # P0081761
Secondary ID IRB201400318
Status Completed
Phase N/A
First received
Last updated
Start date November 6, 2018
Est. completion date May 4, 2022

Study information

Verified date May 2024
Source University of Florida
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study will follow a prospective cohort of racially and economically diverse mothers of premature infants for 3 weeks following delivery to test whether antenatal education of the support person of mothers may decrease time to initiation of breast pumping, decrease time to lactogenesis stage II and increase breast milk production.


Description:

Compelling evidence exists that breast milk helps protect premature infants from prematurity-specific morbidities, including feeding intolerance, late onset sepsis, and necrotizing enterocolitis. Unfortunately, mothers of VLBW infants often exhibit delayed lactogenesis stage II (when the milk "comes in") and inadequate breast milk production. Earlier initiation of breast milk expression following delivery is associated with increased lactation success. However, lack of nursing time and lack of hospital personal are significant barriers to the early initiation of milk expression in this population. The proposed study will follow a prospective cohort of racially and economically diverse mothers of premature infants for 3 weeks following delivery to test 1 primary aim and 1 secondary aim. Aim 1: will evaluate the feasibility of antenatal BM pumping education for SPs of mothers of preterm infants. Issues related to recruitment, randomization acceptance of the intervention, and refinement of the education materials and process will be scrutinized. Aim 2 will estimate variability of outcome measurements and effect sizes needed to calculate the sample size for a subsequent larger, adequately powered, randomized clinical trial. Eligible women and their SP will be randomly assigned to one of two groups. Group 1 will receive a prenatally delivered lactation educational program including video recordings, a demonstration of how the pump works and will have a breast pump available in their room. The volume of breast milk produced, timing of lactation stage II, duration of lactation and stress during initial expression will be measured. In addition, breast milk sodium levels will be analyzed on Day 1-7, Day 14 and 21.


Recruitment information / eligibility

Status Completed
Enrollment 90
Est. completion date May 4, 2022
Est. primary completion date May 4, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: - English speaking - stated intent to breastfeed - anticipating the birth of a premature infant < 35 weeks gestation. Exclusion Criteria: - known illicit maternal drug use - history of breast reduction or augmentation - positive HIV status - infant not expected to live over 2 weeks following delivery.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Prenatally Delivered Lactation Educational Program
The support person (SP) of mothers at risk for preterm birth will be educated on how to use a breast pump and instructions regarding breast milk expression and have a pump in their hospital room

Locations

Country Name City State
United States UF Health at the University of Florida Gainesville Florida

Sponsors (1)

Lead Sponsor Collaborator
University of Florida

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Onset of Lactogenesis Stage II Through Volume Attainment Time in hours until mothers pump at least 20 mL of milk in 2 consecutive pumping sessions Up to 96 Hours
Secondary Breast Milk Production on Day 1 Volume of breast milk produced from 0-24 hours postpartum 0-24 hours postpartum
Secondary Time to Breast Pumping Initiation Time to mothers beginning to pump breasts after delivery first 24 hours after delivery
Secondary Breast Milk Production Day 2 Volume of breast milk produced on day 2 postpartum Day 2 postpartum
Secondary Milk Production Day 3 Volume of milk produced on Day 3 postpartum 3 days postpartum
Secondary Breast Milk Production Day 4 Volume of breast milk produced on Day 4 postpartum Day 4 postpartum
Secondary Breast Milk Production on Day 5 Volume of breast milk produced on Day 5 postpartum Day 5 postpartum
Secondary Breast Milk Production Day 6 Volume of breast milk produced on Day 6 postpartum Day 6 postpartum
Secondary Breast Milk Production Day 7 Volume of milk produced on Day 7 postpartum Day 7 postpartum
Secondary Breast Milk Production Day 14 Volume of breast milk produced on Day 14 postpartum Day 14 postpartum
Secondary Breast Milk Production Day 21 Volume of breast milk produced on Day 21 postpartum 21 days postpartum
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05934318 - L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) N/A
Completed NCT05502510 - Assessing the Effectiveness and Efficacy of the MyHealthyPregnancy Application
Not yet recruiting NCT03418311 - Cervical Pessary Treatment for Prevention of s PTB in Twin Pregnancies on Children`s Long-Term Outcome N/A
Not yet recruiting NCT03418012 - Prevention of sPTB With Early Cervical Pessary Treatment in Women at High Risk for PTB N/A
Completed NCT02993744 - Maternal Inflammatory Parameters Within Routine Treatment With Betamethasone N/A
Active, not recruiting NCT02673216 - Infection and Adverse Pregnancy Outcome
Completed NCT01683565 - Preemie Tots: A Pilot Study to Understand the Effects of Prematurity in Toddlerhood Phase 4
Completed NCT01460576 - Improving Prematurity-Related Respiratory Outcomes at Vanderbilt N/A
Completed NCT01412931 - Protein and Ultrasound Indicators of Preterm Birth N/A
Completed NCT02606058 - The Australian Placental Transfusion Study (APTS): Should Very Pre Term Babies Receive a Placental Blood Transfusion at Birth Via Deferring Cord Clamping Versus Standard Cord Clamping Procedures? N/A
Terminated NCT03715530 - Use of Placental Alpha Microglobulin-1(PAMG-1) to Diagnose Premature Rupture of Membranes in Pregnant Women N/A
Completed NCT00422526 - Progesterone for Prevention of Preterm Birth in Women With Short Cervix: Randomized Controlled Trial Phase 3
Enrolling by invitation NCT04251260 - Effectiveness of Positioning in Preterm Neonates N/A
Completed NCT03668860 - India Dexamethasone and Betamethasone Phase 1
Recruiting NCT03638037 - Correlation Between Maternal Vitamin D Level And Preterm Birth
Completed NCT02225353 - Efficacy Study of a Cervical Pessary Containing Progesterone for the Prevention of Preterm Delivery Phase 2
Recruiting NCT03992534 - The FLIP-1 Study: Vaginal Lactobacillus Supplementation in Women at High Risk of Preterm Birth Phase 1
Completed NCT03144141 - Association Between EHG and Risk of Preterm Delivery in Women Hospitalized for Threatened Premature Delivery N/A
Completed NCT05210985 - Examination of the Relationship Between Home Affordances With Development
Completed NCT04811742 - Effect of Immersion Bathing and Showering Applications on Comfort Level and Physiological Parameters of Newborn N/A